0000950170-24-052877.txt : 20240503 0000950170-24-052877.hdr.sgml : 20240503 20240503160522 ACCESSION NUMBER: 0000950170-24-052877 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240419 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ATAI Life Sciences AG CENTRAL INDEX KEY: 0001776242 ORGANIZATION NAME: STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31187 FILM NUMBER: 24912971 BUSINESS ADDRESS: STREET 1: KRAUSENSTRASSE 9-10 CITY: BERLIN STATE: 2M ZIP: 10117 BUSINESS PHONE: 4917632963813 MAIL ADDRESS: STREET 1: KRAUSENSTRASSE 9-10 CITY: BERLIN STATE: 2M ZIP: 10117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31187 FILM NUMBER: 24912972 BUSINESS ADDRESS: STREET 1: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 BUSINESS PHONE: (617)-699-5876 MAIL ADDRESS: STREET 1: 524 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10013 FORMER NAME: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IntelGenx Technologies Corp. CENTRAL INDEX KEY: 0001098880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870638336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6420 ABRAMS CITY: SAINT LAURENT STATE: A8 ZIP: H4S 1Y2 BUSINESS PHONE: 514-331-7440 MAIL ADDRESS: STREET 1: 6420 ABRAMS CITY: SAINT LAURENT STATE: A8 ZIP: H4S 1Y2 FORMER COMPANY: FORMER CONFORMED NAME: BIG FLASH CORP DATE OF NAME CHANGE: 19991112 4 1 ownership.xml 4 X0508 4 2024-04-19 0001098880 IntelGenx Technologies Corp. IGXT 0001840904 ATAI Life Sciences N.V. WALLSTRABE 16 BERLIN 2M 10179 GERMANY false false true false 0001776242 ATAI Life Sciences AG WALLSTRABE 16 BERLIN 2M 10179 GERMANY false false true false false Convertible Notes 0.185 2024-04-19 4 J false 1000000 A 2024-04-19 2026-02-01 Common Stock 5405405 10500000 I By ATAI Life Sciences AG On April 19, 2024, pursuant to the Third Amended and Restated Loan Agreement, ATAI AG provided to IntelGenX Corp. an additional term loan in an amount equal to $1,000,000, which is convertible to shares of Common Stock at a price of $0.185 per share. Any accrued interest outstanding under the loan may be converted into shares of Common Stock at the five day volume weighted average price of the shares, less the maximum permitted discount under certain applicable rules, ending on the day that is the second business day before the day the interest becomes due and payable. Reflects securities held of record by ATAI AG, which is a wholly owned subsidiary of ATAI Life Sciences N.V., and as a result, ATAI Life Sciences N.V. may be deemed to share beneficial ownership over the securities reported herein. ATAI Life Sciences N.V., By: /s/ Florian Brand, Chief Executive Officer 2024-05-03 ATAI Life Sciences AG, By: /s/ Florian Brand, Chief Executive Officer 2024-05-03